Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Skye Bioscience Uplists to The Nasdaq Global Market
Read Article
News
2024
2023
Archive
Search news articles
January 5, 2017
APREA THERAPEUTICS ANNOUNCES PRESENTATION AT THE 35TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE IN SAN FRANCISCO
December 12, 2016
FLEXION THERAPEUTICS SUBMITS NEW DRUG APPLICATION FOR ZILRETTA™ TO TREAT KNEE OSTEOARTHRITIS PAIN
December 12, 2016
ACHAOGEN ANNOUNCES POSITIVE RESULTS IN PHASE 3 CUTI AND CRE CLINICAL TRIALS OF PLAZOMICIN
December 12, 2016
ARVINAS PRESENTS DATA ON ORAL ESTROGEN RECEPTOR PROTAC DEGRADER AT 2016 SAN ANTONIO BREAST CANCER SYMPOSIUM
December 9, 2016
ARVINAS COLLABORATORS PRESENT DATA ON BET PROTAC DEGRADERS AT 2016 ASH ANNUAL MEETING
December 5, 2016
NOHLA THERAPEUTICS ANNOUNCES CLOSING OF $43.5M SERIES A FINANCING TO TRANSFORM STEM CELL TRANSPLANTATION WITH INNOVATIVE OFF THE SHELF, UNIVERSAL DONOR CELLULAR THERAPY
November 29, 2016
ARVINAS PRESENTS DATA ON ITS BET PROTAC DEGRADERS AT 2016 EORTC-NCI-AACR SYMPOSIUM
November 29, 2016
AUDENTES THERAPEUTICS ANNOUNCES INITIATION OF LARGE-SCALE CGMP PRODUCTION AT ITS GENE THERAPY MANUFACTURING FACILITY
November 28, 2016
PHASERX RECEIVES ORPHAN DRUG DESIGNATION FROM FDA FOR PRX-OTC FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
November 10, 2016
CIDARA PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS
« Previous Page
1
…
88
89
90
91
92
…
118
Next Page »